182 related articles for article (PubMed ID: 34657563)
1.
Cheepurupalli L; Diaz A; Gopal AC; Rathore SS; Ramakrishnan V; Ramakrishnan J
J Biomol Struct Dyn; 2022; 40(24):13593-13605. PubMed ID: 34657563
[TBL] [Abstract][Full Text] [Related]
2. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in
Wachino J-i; Jin W; Norizuki C; Kimura K; Tsuji M; Kurosaki H; Arakawa Y
Microbiol Spectr; 2024 Mar; 12(3):e0234423. PubMed ID: 38315122
[TBL] [Abstract][Full Text] [Related]
4. 1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing
Somboro AM; Amoako DG; Osei Sekyere J; Kumalo HM; Khan R; Bester LA; Essack SY
Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478231
[TBL] [Abstract][Full Text] [Related]
5. Novel metallo-β-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria.
Guo Y; Liu H; Yang M; Ding R; Gao Y; Niu X; Deng X; Wang J; Feng H; Qiu J
Br J Pharmacol; 2024 Jan; 181(1):54-69. PubMed ID: 37539785
[TBL] [Abstract][Full Text] [Related]
6.
Cervino I; Gonzalez D; Nastro M; Vega J; Reyes AP; Buriano G; Vay C; Famiglietti A; Rodriguez CH
J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34605763
[TBL] [Abstract][Full Text] [Related]
7. In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant
Peters BK; Reddy N; Shungube M; Girdhari L; Baijnath S; Mdanda S; Chetty L; Ntombela T; Arumugam T; Bester LA; Singh SD; Chuturgoon A; Arvidsson PI; Maguire GEM; Kruger HG; Naicker T; Govender T
ACS Infect Dis; 2023 Mar; 9(3):486-496. PubMed ID: 36786013
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and
Moreira JS; Galvão DS; Xavier CFC; Cunha S; Pita SSDR; Reis JN; Freitas HF
J Biomol Struct Dyn; 2022; 40(24):14223-14235. PubMed ID: 34766882
[TBL] [Abstract][Full Text] [Related]
9. Isolation of the first New Delhi metallo-ß-lactamase-1 (NDM-1)-producing and colistin-resistant Klebsiella pneumoniae sequence type ST15 from a digestive carrier in Albania, May 2018.
Tafaj S; Gona F; Kapisyzi P; Cani A; Hatibi A; Bino S; Fico A; Koraqi A; Kasmi G; Cirillo D
J Glob Antimicrob Resist; 2019 Jun; 17():142-144. PubMed ID: 30557684
[TBL] [Abstract][Full Text] [Related]
10. Captopril potentiated meropenem activity against MBL-producing carbapenem-resistant Klebsiella pneumoniae: in vitro and in vivo study.
Zhao D; Li H; Yue C; Sun K; Dai Y; Zhang H; Liu Y; Gao Y; Li J
J Inorg Biochem; 2021 May; 218():111381. PubMed ID: 33647540
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of metallo-β-lactamase acquired genes among carbapenems susceptible and resistant Gram-negative clinical isolates using multiplex PCR, Khartoum hospitals, Khartoum Sudan.
Adam MA; Elhag WI
BMC Infect Dis; 2018 Dec; 18(1):668. PubMed ID: 30558551
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive screening of marine metabolites against class B1 metallo-β-lactamases of
Diaz A; G S; Balaji S; Ramakrishnan J; Thamotharan S; Ramakrishnan V
J Biomol Struct Dyn; 2023 Dec; 41(20):10930-10943. PubMed ID: 36541935
[TBL] [Abstract][Full Text] [Related]
13. Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.
Chen AY; Thomas PW; Stewart AC; Bergstrom A; Cheng Z; Miller C; Bethel CR; Marshall SH; Credille CV; Riley CL; Page RC; Bonomo RA; Crowder MW; Tierney DL; Fast W; Cohen SM
J Med Chem; 2017 Sep; 60(17):7267-7283. PubMed ID: 28809565
[TBL] [Abstract][Full Text] [Related]
14. Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases.
Muhammad Z; Skagseth S; Boomgaren M; Akhter S; Fröhlich C; Ismael A; Christopeit T; Bayer A; Leiros HS
Bioorg Med Chem; 2020 Aug; 28(15):115598. PubMed ID: 32631568
[TBL] [Abstract][Full Text] [Related]
15. Suppression of β-Lactam Resistance by Aspergillomarasmine A Is Influenced by both the Metallo-β-Lactamase Target and the Antibiotic Partner.
Rotondo CM; Sychantha D; Koteva K; Wright GD
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932375
[TBL] [Abstract][Full Text] [Related]
16. In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates.
Meletiadis J; Paranos P; Georgiou PC; Vourli S; Antonopoulou S; Michelaki A; Vagiakou E; Pournaras S
Int J Antimicrob Agents; 2021 Nov; 58(5):106440. PubMed ID: 34551356
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors.
Schnaars C; Kildahl-Andersen G; Prandina A; Popal R; Radix S; Le Borgne M; Gjøen T; Andresen AMS; Heikal A; Økstad OA; Fröhlich C; Samuelsen Ø; Lauksund S; Jordheim LP; Rongved P; Åstrand OAH
ACS Infect Dis; 2018 Sep; 4(9):1407-1422. PubMed ID: 30022668
[TBL] [Abstract][Full Text] [Related]
18. Pterostilbene restores carbapenem susceptibility in New Delhi metallo-β-lactamase-producing isolates by inhibiting the activity of New Delhi metallo-β-lactamases.
Liu S; Zhang J; Zhou Y; Hu N; Li J; Wang Y; Niu X; Deng X; Wang J
Br J Pharmacol; 2019 Dec; 176(23):4548-4557. PubMed ID: 31376166
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of metal chelators as potential metallo- β -lactamase inhibitors.
Azumah R; Dutta J; Somboro AM; Ramtahal M; Chonco L; Parboosing R; Bester LA; Kruger HG; Naicker T; Essack SY; Govender T
J Appl Microbiol; 2016 Apr; 120(4):860-7. PubMed ID: 26849010
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of metallo-β-lactamase among carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China.
Li B; Xu XH; Zhao ZC; Wang MH; Cao YP
Can J Microbiol; 2014 Oct; 60(10):691-5. PubMed ID: 25285938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
